The biology of rotator cuff repair: why technique has hit a ceiling.

Twenty years of technique.

The contemporary rotator cuff repair is a different operation from the one I trained on. Single-row repairs gave way to double-row constructs. Double-row gave way to suture-bridge and transosseous-equivalent. The biomechanics got better. The footprint coverage got better. The published re-tear rates, in well-selected tears with well-selected technique, are reasonable.

And yet, in clinic, we still see the patient who has done everything right — the right surgeon, the right operation, the right post-op protocol — whose MRI at six months shows a re-tear. The cuff did not heal. The technique was sound. The biology was not.

The biology is doing more work than the technique now.

The shift in thinking that came out of the recent Smith+Nephew Inspire Shoulder course in Singapore — and the Sydney faculty week that followed it — is that the technique has hit a practical ceiling.¹ The next frontier is biological. Three biological levers, and one important caveat.

1. Pre-operative nutrition.

Tendon heals on collagen synthesis. Collagen synthesis depends on protein, on vitamin C, on vitamin D, on adequate caloric intake. Patients with low serum vitamin D, low protein intake, or sarcopenia heal tendon poorly. This is not new biology — it is well-described in the published literature.² What is new is the willingness to act on it before the operation.

Starting in clinic now: every patient considering elective cuff repair gets a conversation about nutrition. Where indicated, a serum vitamin D level. Where deficient, supplementation before the operation date. Where there is meaningful malnutrition or sarcopenia, a referral to a dietitian or, in older patients, to a geriatrician for medical optimisation. The operation date moves to accommodate the biology — the biology does not get rushed to accommodate the date.

2. Metabolic optimisation.

Three modifiable factors meaningfully affect cuff healing:

• Smoking. Nicotine reduces tendon perfusion. Smokers heal worse cuff. The data is no longer subtle.³ Cessation, ideally several weeks before surgery, is now a non-negotiable conversation.
• Diabetes & glycaemic control. Uncontrolled diabetes degrades collagen and impairs tendon healing. HbA1c above 8% at the time of elective cuff repair is a flag to optimise before booking.
• Vitamin D deficiency. Severe deficiency is associated with worse tendon-to-bone healing in published series. Replacement is cheap and benign.

None of this is exotic. All of it is doable in the eight to twelve weeks between the decision to operate and the operation date. The reason it has not been routine until now is that surgeons have, historically, viewed pre-operative optimisation as the GP's job, the anaesthetist's job, or the patient's job. The biology suggests we own a meaningful part of it.

3. Intra-operative augmentation.

The most visible change in the field is the move from technique-only repairs to biologically-augmented repairs in patients whose tissue we cannot trust. The two technologies most discussed in 2026:

• REGENETEN — a bio-inductive collagen implant placed over the cuff repair to recruit host cells and improve tendon healing. The clinical data is most convincing in larger tears and re-tears.
• ENFIX-class augmentations — the newer generation of peptide-loaded suture-anchor and patch technologies that aim to improve the local healing environment at the bone–tendon interface.

The clinical question is no longer "should we augment" — it is "in which patient does augmentation move the curve enough to justify the cost." The honest answer, today, is: re-tears, larger tears, smokers, diabetics, and patients whose tendon quality at the time of surgery is poor.

The caveat: peptides.

The conversation about biology in 2026 inevitably runs into the conversation about peptides — BPC-157, TB-500, the GLP-1 family. Patients have read about them, gym contacts are using them, and the marketing has run ahead of the science.

The orthopaedic evidence base for peptide therapy in tendon healing is thin. The safety data is thinner. The Australian regulatory picture is unclear. The honest position: I am not prescribing peptides for tendon healing. I am also not dismissing the question — patients deserve a serious answer rather than a brush-off.

Where this needs to go: properly designed clinical trials, with proper safety endpoints, properly registered. The pressure is real; the answer has to come from data, not anecdote. The University of the Sunshine Coast research partnership is where I would start.

What this means for your shoulder.

If you have been told you need a rotator cuff repair, three questions are worth asking your surgeon before the operation date is set:

1. What is my vitamin D level, and is it being replaced?
2. If I smoke, what is the cessation plan?
3. Given the imaging picture of my cuff and my metabolic profile, will the repair be biologically augmented — and if so, with what?

None of these questions are critical of your surgeon. They are an opening to the conversation that the field has finally caught up to. The shoulder you need back is the one that heals — not the one that gets repaired.

References.

1. Smith+Nephew Medical Education. Inspire Shoulder Course, Singapore, May 2026. Course materials and faculty lectures by Chris Peach, John Trantalis, Alan Wang, Ian Lo, and Fay Leung. Companion note: Notes from Singapore and Sydney.
2. Angeline ME, et al. Effect of diet-induced vitamin D deficiency on rotator cuff healing in a rat model. Am J Sports Med. 2014;42(1):27–34.
3. Mall NA, et al. Smoking and rotator cuff repair: a clinical review. J Shoulder Elbow Surg. 2015;24(3):485–494.